• AdvaMed Applauds Outcome Of JCCT In Chicago

    By: Press Release | December 22, 2014

    Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), today released the following statement in response to the outcome of the 25th U.S.-China Joint Commission on Commerce and Trade (JCCT) in Chicago, Ill., on Dec. 16-18.

  • BD Chairman, President and CEO Vincent Forlenza Named Chairman of AdvaMed's Board of Directors

    By: Press Release | December 17, 2014

    The Advanced Medical Technology Association (AdvaMed) today announced that BD Chairman, President and CEO Vincent A. Forlenza has been named chairman of the AdvaMed Board of Directors for a two-year term.

  • AdvaMed Applauds Japan's New Device Regulatory Framework

    By: Press Release | November 25, 2014

    Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), today released a statement in conjunction with the Nov. 25 implementation date for Japan’s new Pharmaceutical and Medical Device Law (PMDL).

Payment Review & Alerts

The Payment & Policy Review is a new monthly communication from AdvaMed’s Payment and Health Care Delivery Policy Department that provides a short summary of important activities, reports, letters, meetings, etc. that relate to Medicare payment, coverage and quality issues.


  • 510(k) Submission Workshop

    February 23-24, 2015| FDA Staff (invited) and industry experts are coming together to discuss 510(k) Submissions.  This interactive workshop will cover FDA updates, regulatory routes, factors to consider when assembling a 510(k... more

  • IDE Submissions Workshop

    During this interactive workshop, FDA Staff Leaders (invited) and Industry Experts will lead professionals through the regulatory and practical guidelines governing when an investigational device exemption (IDE) is required.  T... more